ondasdechoque.org
PT-BR

Chronic plantar fasciitis: success rates pooled by shockwave type · Review · 2017

Does shockwave help long-lasting heel pain more than sham?

In this review of 9 sham-controlled trials, more people reached each trial’s success goal after shockwave, over 6 weeks to 6 months, most consistently with focused devices. One trial drove the size of the radial result; without it, radial still favoured shockwave.

Helped more than sham
trials against sham
9
adults with long-lasting heel pain
935
focused-device trials; 3 classed as radial
6

Good to know: Trials that gave everyone a numbing injection were left out.

Sun J, Gao F, Wang Y, et al. Medicine (Baltimore), 2017 · Read the paper ↗

How this study worked

9 studies935 peopleOne answer
A review gathers earlier studies to answer one question.

What happened

studies
9
people
935
Compared with
Sham shockwave

Chance of success vs sham

Odds ratio · above 1 means more successes with shockwave

The odds of success were about 2.6 times higher with shockwave across 9 trials, 2.2 with focused devices and 2.4 for radial once its outlying trial was left out.
Show the numbers
Odds ratiolikely range
All 9 trials2.581.97 to 3.39
6 focused trials2.171.49 to 3.16
Radial, without the outlying trial2.391.57 to 3.65

What the trials used

Focused regimens
Rompe 1996 0.06 mJ/mm², 1,000 pulses ×3; Speed 2003 0.12, 1,500 ×3; Rompe 2003 0.16, 2,100 ×3; Marks 2008 0.16, 1,500 ×3; Gollwitzer 2007 and 2015 0.25, 2,000 ×3. Trials applying local anaesthesia to all patients were excluded.
Regimens classed as radial
Gerdesmeyer 2008 0.16 mJ/mm², 2,000 pulses ×3; Ibrahim 2010 0.16, 2,000 ×2; Malay 2006 a total of 3,800 pulses, intensity not available.
Sham methods
Sham treatments: air-filled or foil standoffs, foam-insulated membrane, sound-reflecting pad, zero- or minimal-energy pulses, a heel clasp, a placebo handpiece, or the applicator held 1 cm away.
Device classification check
Malay 2006 describes an electrohydraulic spark-gap device with a semi-ellipsoid reflector; the trial report does not call it radial, although it says the energy is dispersed over a treatment area large enough that no targeting is needed. Marks 2008 is listed as focused although its reference title describes a new-generation pneumatic device.

Who took part

Adults with long-lasting plantar heel pain, with average ages of 40 to 59, in 9 trials from 1996 to 2015.

Side effects

No serious problems were recorded; a few people had discomfort, pain, swelling or bruising.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

Adults with chronic plantar fasciitis in 9 sham-controlled RCTs (1996–2015), 935 patients: 6 trials of focused and 3 classed as radial shockwaves. Trials giving local anaesthesia to all patients were excluded. Group mean ages 40 to 58.9 years; follow-up 6 weeks to 6 months.

Treatment success, all shockwaves4 reported outcomes
01
Trial-specific, 6 weeks to 6 months

Treatment success, all shockwaves

Treatment success: >50% or >60% VAS improvement from baseline or similar, per trial odds of treatment success

OR2.58CI 95% 1.97 to 3.39p <0.00001

Shockwaves versus sham

9 studies · 935 participants in this estimate · I²=38%; Chi²=12.81, df=8, P=0.12

Mantel–Haenszel fixed-effect model

0.9Equal results 13.9

Logarithmic ratio scale.

Across 9 trials more patients reached the trial-defined success threshold after shockwaves than after sham (275/506 versus 141/429 in Figure 4).

Analysis details and source

Success definitions differed (>50%, >60%, VAS <4 cm; Rompe 1996 had no stated criterion). Figure 4 uses 12/22 versus 6/23 for Rompe 2003 and 17/46 versus 10/42 for Speed 2003, whereas Table 1 lists 12/19, 6/20, 17/42 and 10/34. Ibrahim 2010 (25/25 versus 4/25) has OR 243.67.

02
Trial-specific, 6 weeks to 6 months

Treatment success, focused shockwaves

Treatment success: >50% or >60% VAS improvement from baseline or similar, per trial odds of treatment success

OR2.17CI 95% 1.49 to 3.16p <0.0001

Shockwaves versus sham

6 studies · 474 participants in this estimate · I²=0%; Chi²=2.22, df=5, P=0.82

Mantel–Haenszel fixed-effect model

0.9Equal results 13.6

Logarithmic ratio scale.

In 6 focused-device trials more patients reached success after shockwaves (127/244 versus 77/230), with consistent results across trials. Speed 2003 and Marks 2008 alone showed no significant difference.

Analysis details and source

The text describes 474 patients “with 244 events”; Figure 5 shows 244 as the treated-arm total and 127 events. Marks 2008 is classed as focused although its title describes a pneumatic device.

03
Trial-specific, 6 weeks to 6 months

Treatment success, radial shockwaves

Treatment success: >50% or >60% VAS improvement from baseline or similar, per trial odds of treatment success

OR4.63CI 95% 1.3 to 16.46p = 0.02

Shockwaves versus sham

3 studies · 461 participants in this estimate · I²=81%; Tau²=0.86; Chi²=10.47, df=2, P=0.005

Random-effects model

0.7Equal results 123

Logarithmic ratio scale.

The pooled radial estimate favoured shockwaves but with a very wide interval and large between-trial differences.

Analysis details and source

Three trials: Gerdesmeyer 2008 OR 2.11 (1.27–3.52), Ibrahim 2010 OR 243.67 (12.41–4785.60) and Malay 2006 OR 3.07. Malay 2006 describes an electrohydraulic semi-ellipsoid device, which its report does not call radial. Text gives 461 patients “with 262 events”; Figure 6 shows 262 as treated total and 148 events.

04
Trial-specific, 6 weeks to 6 months

Radial success without Ibrahim 2010

Treatment success: >50% or >60% VAS improvement from baseline or similar, per trial odds of treatment success

OR2.39CI 95% 1.57 to 3.65p <0.0001

Radial shockwaves versus sham, Ibrahim 2010 excluded

2 studies

Sensitivity analysis; model not stated

0.9Equal results 14.3

Logarithmic ratio scale.

Removing the outlying Ibrahim trial left Gerdesmeyer 2008 and Malay 2006, still favouring shockwaves with a narrower interval.

Analysis details and source

Sensitivity analysis reported only in the Discussion; model and participant count not stated. One of the two remaining trials (Malay) may not be a radial device. Excluding Malay instead gave OR 18.34 (0.14–2413.75), I²=90%, which the authors still describe as efficacy.

Reduction in pain scale, all shockwaves2 reported outcomes
05
Trial-specific, 6 weeks to 6 months

Reduction in pain scale, all shockwaves

Reduction in pain scale (VAS-based, trial-specific) standardized mean difference units

SMD1.01CI 95% -0.01 to 2.03p = 0.05

Shockwaves versus sham

4 studies · I²=96%; Tau²=1.00; Chi²=72.62, df=3, P<0.00001

Random-effects model

-0.3Equal results 02.3

Pooled pain reduction was larger with shockwaves on average, but the 95% CI reaches −0.01 and the trials differed greatly (I²=96%).

Analysis details and source

Positive SMD means greater pain reduction with shockwaves, although the axis labels this side “favours control”, and the abstract calls it a “markedly lower” SMD. The text says the trials reported standard errors; Gollwitzer 2015 values (6.8, 7.2) entered in the SD column match Table 1 values in parentheses. If these are SEs, its SMD of 2.02 would be overstated (extractor interpretation). Figures 7 and 8 give Gollwitzer 125 and 124 treated.

06
Trial-specific, 6 weeks to 6 months

Reduction in pain scale, focused shockwaves

Reduction in pain scale (VAS-based, trial-specific) standardized mean difference units

SMD1.29CI 95% 0.39 to 2.19p = 0.005

Focused shockwaves versus sham

3 studies · I²=87%; Tau²=0.53; Chi²=14.87, df=2, P=0.0006

Random-effects model

-0.3Equal results 02.5

In 3 focused-device trials pain reduction was larger with shockwaves, with very high between-trial differences.

Analysis details and source

Driven by Gollwitzer 2015 (SMD 2.02); Marks 2008 alone 0.76 (−0.09 to 1.61). Excluding Gollwitzer from the 4-trial analysis gave SMD 0.57 (0.12–1.01), p=.01 (Discussion).

How treatment was delivered
Focused regimens

Rompe 1996 0.06 mJ/mm², 1,000 pulses ×3; Speed 2003 0.12, 1,500 ×3; Rompe 2003 0.16, 2,100 ×3; Marks 2008 0.16, 1,500 ×3; Gollwitzer 2007 and 2015 0.25, 2,000 ×3. Trials applying local anaesthesia to all patients were excluded.

Regimens classed as radial

Gerdesmeyer 2008 0.16 mJ/mm², 2,000 pulses ×3; Ibrahim 2010 0.16, 2,000 ×2; Malay 2006 a total of 3,800 pulses, intensity not available.

Sham methods

Sham treatments: air-filled or foil standoffs, foam-insulated membrane, sound-reflecting pad, zero- or minimal-energy pulses, a heel clasp, a placebo handpiece, or the applicator held 1 cm away.

Device classification check

Malay 2006 describes an electrohydraulic spark-gap device with a semi-ellipsoid reflector; the trial report does not call it radial, although it says the energy is dispersed over a treatment area large enough that no targeting is needed. Marks 2008 is listed as focused although its reference title describes a new-generation pneumatic device.

HARMS & TOLERABILITY

Seven of 9 trials described complications. No serious adverse events (such as haematoma or infection) were recorded; a few patients had discomfort, pain, swelling or bruising during or after treatment. No pooled harm estimate was made, and two trials did not describe complications, so the authors’ statement that ESWT is safe rests on limited reporting.

LIMITS OF THE ANALYSIS

Title versus conclusion: the title says ESWT “is effective”, but the abstract and conclusion say no firm conclusion can be drawn about ESWT overall or radial therapy. The Discussion’s opening says ESWT and radial therapy “might be more effective than placebo and FSW therapy”, while the conclusion favours focused therapy.

Reporting errors: subgroup “events” in the text (244, 262) are treated-arm totals in Figures 5–6; Table 1 and Figure 4 disagree on Rompe 2003 and Speed 2003 counts; the abstract calls a positive SMD “markedly lower”; forest-plot axis labels are reversed relative to the data.

Pain-scale synthesis: only 4 trials, I²=96%, mixed units in Table 1 (percentages and points), and values described as standard errors appear in the SD column (extractor interpretation).

Device classification: Malay 2006 (electrohydraulic) is analysed as radial and Marks 2008 (pneumatic per its title) as focused; Ibrahim 2010 (25/25 successes) dominates radial heterogeneity.

Author-reported limits: English-only search to July 2016; some participants received local anaesthesia for intolerable pain; functional recovery could not be analysed; no direct focused-versus-radial trials pooled. Risk of bias was mostly rated low; Rompe 1996 was unclear in four domains.

Funding: National Natural Science Foundation of China, Beijing Natural Science Foundation and China-Japan Friendship Hospital research funds; the authors report no conflicts of interest.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Title versus conclusion: the title says ESWT “is effective”, but the abstract and conclusion say no firm conclusion can be drawn about ESWT overall or radial therapy. The Discussion’s opening says ESWT and radial therapy “might be more effective than placebo and FSW therapy”, while the conclusion favours focused therapy.
  • Reporting errors: subgroup “events” in the text (244, 262) are treated-arm totals in Figures 5–6; Table 1 and Figure 4 disagree on Rompe 2003 and Speed 2003 counts; the abstract calls a positive SMD “markedly lower”; forest-plot axis labels are reversed relative to the data.
  • Pain-scale synthesis: only 4 trials, I²=96%, mixed units in Table 1 (percentages and points), and values described as standard errors appear in the SD column (extractor interpretation).
  • Device classification: Malay 2006 (electrohydraulic) is analysed as radial and Marks 2008 (pneumatic per its title) as focused; Ibrahim 2010 (25/25 successes) dominates radial heterogeneity.
  • Author-reported limits: English-only search to July 2016; some participants received local anaesthesia for intolerable pain; functional recovery could not be analysed; no direct focused-versus-radial trials pooled. Risk of bias was mostly rated low; Rompe 1996 was unclear in four domains.
  • Funding: National Natural Science Foundation of China, Beijing Natural Science Foundation and China-Japan Friendship Hospital research funds; the authors report no conflicts of interest.
Research review

Source-linked critical reading

Systematic review and meta-analysis

Reading depthMaterial consulted
Technical source record

Complete local PDF read (all 7 pages), including Table 1, all eight figures checked on page images, discussion, funding and references. The included Malay 2006 trial was also read in full to check its device classification; other included trials were not reread.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Study design

Systematic review and meta-analysis following PRISMA: PubMed, Medline, Embase, Web of Science and Cochrane Library to July 2016, English only. Nine sham-controlled RCTs (935 patients) included; Cochrane risk-of-bias tool; RevMan 5.3, fixed effects when I²<50%, otherwise random effects.

Participants and setting

Adults with chronic plantar fasciitis in 9 sham-controlled RCTs (1996–2015), 935 patients: 6 trials of focused and 3 classed as radial shockwaves. Trials giving local anaesthesia to all patients were excluded. Group mean ages 40 to 58.9 years; follow-up 6 weeks to 6 months.

Treatment

Focused shockwaves (0.06–0.25 mJ/mm², 1,000–2,100 pulses, 3 sessions) and shockwaves classed as radial (0.16 mJ/mm², 2,000 pulses, 2–3 sessions; one trial a single 3,800-pulse session). Two classifications are open to question. Malay 2006 describes an electrohydraulic device and Marks 2008 a pneumatic one.

Comparison

Sham treatments: air-filled or foil standoffs, foam-insulated membrane, sound-reflecting pad, zero- or minimal-energy pulses, a heel clasp, a placebo handpiece, or the applicator held 1 cm away.

Outcomes and timing

Treatment success as defined by each trial (mostly >50% or >60% VAS improvement, or VAS <4 cm), pooled as odds ratios; reduction in pain scale in 4 trials as standardized mean differences; complications. Follow-up 6 weeks to 6 months; function was not analysed.

What the results show

Success: all shockwaves OR 2.58 (95% CI 1.97–3.39), 9 trials, I²=38%; focused OR 2.17 (1.49–3.16), 6 trials, I²=0%; radial OR 4.63 (1.30–16.46), 3 trials, I²=81%, and OR 2.39 (1.57–3.65) without the outlying Ibrahim trial; Gerdesmeyer 2008 alone OR 2.11 (1.27–3.52). Pain reduction: SMD 1.01 (−0.01 to 2.03), p=.05, I²=96%; focused 1.29 (0.39–2.19), I²=87%; without Gollwitzer 2015, 0.57 (0.12–1.01). Two focused trials, Speed 2003 and Marks 2008, showed no significant difference on their own.

Harms

Seven of 9 trials described complications. No serious adverse events (such as haematoma or infection) were recorded; a few patients had discomfort, pain, swelling or bruising during or after treatment. No pooled harm estimate was made, and two trials did not describe complications, so the authors’ statement that ESWT is safe rests on limited reporting.

Limits and disclosures

The title (“is effective”) goes beyond the conclusion, which reserves judgment on ESWT overall and on radial therapy. The text mislabels treated-arm totals as events; Table 1 and Figure 4 counts disagree for two trials; forest-plot axis labels run opposite to the data; and values described as standard errors may have been used as SDs. Malay 2006 (electrohydraulic) is analysed as radial and Marks 2008 (pneumatic) as focused. English-only search; high heterogeneity for radial and pain outcomes; function not analysed. Government and hospital funding; no conflicts declared.

Application to care

Applies to adults with chronic plantar fasciitis treated without routine local anaesthesia and compared with sham over at most 6 months. The focused-device success result is the most consistent; the radial and pain-scale figures need verification, and the review cannot say which device type works better.

What remains to be tested

Reanalyse with verified arm counts, correct device classification and consistent SD/SE handling; trials comparing focused and radial devices directly with function outcomes and longer follow-up.

THE ORIGINAL SOURCE

Read the original article.

Extracorporeal shock wave therapy is effective in treating chronic plantar fasciitis: A meta-analysis of RCTs.

Sun J, Gao F, Wang Y, Sun W, Jiang B, Li Z. · Medicine (Baltimore) · 2017

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →